CTNNB1 and breast carcinoma: It is tempting to speculate that CS-E treatment of breast cancer cells might identifiy similar Wnt/beta-catenin signaling thresholds, and therefore only affects a subset of Wnt/beta-catenin target genes and/or biological readouts.